BELLEVUE GROUP AG Denali Therapeutics Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$951,000
portfolio value

Denali Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 31K shares 951K $30.69 31K